Open Access Peer-Reviewed
Artigo Original

Evaluation of the impact of binocular versus monocular cataract surgery using Catquest-9SF: a randomized controlled trial

Evaluation of the impact of binocular versus monocular cataract surgery using Catquest-9SF: a randomized controlled trial

Helmer Magalhães Antunes1,2; Galton Carvalho Vasconcelos1; Bruno Lovaglio Cançado Trindade3,4

DOI: 10.5935/0004-2749.2023-0268

ABSTRACT

PURPOSE: This prospective, randomized, unmasked, clinical trial aimed to report the visual outcomes of cataract surgery on both eyes versus cataract surgery on one eye in Brazilian patients.
METHODS: This study included patients with bilateral cataracts and binocular visual acuity worse than or equal to 0.3 logarithm of the minimum angle of resolution. The patients were randomly assigned to undergo surgery on one (Control Group) or both eyes (one eye at a time; Intervention Group). Postoperatively, self-reported visual function using Catquest-9SF (primary outcome measure), binocular visual acuity, stereopsis, and ocular dominance (secondary outcome measures) were compared.
RESULTS: A total of 151 patients (77 and 148 eyes in the Control and Intervention Groups, respectively) completed the follow-up. Patients who underwent surgery on both eyes exhibited significantly better self-reported visual function (p=0.036) and stereopsis (p=0.026) than those who underwent surgery on one eye. Binocular visual acuity and ocular dominance did not affect the group comparisons.
CONCLUSIONS: Surgery on both eyes resulted in significantly better self-reported visual function and stereopsis than surgery on one eye.

Keywords: Cataract; Cataract extraction; Quality of life; Treatment outcome; Visual acuity; Binocular vision; Stereopsis

INTRODUCTION

Cataract surgery on the second eye after the first eye has been surgically treated is common. It has become a standard clinical approach, subject to specific indications for each case. Due to the increasing number of cost-effectiveness studies in health care in recent years, cataract surgery on the second eye purportedly has limited clinical value(1,2). Cataract surgery on one eye can improve daily visual function(3,4), reduce the risk of falls, and decrease the incidence of fractures(5,6) and other adverse events. However, surgery on the second eye can improve visual acuity, contrast sensitivity, and stereopsis(6-9).

A recent meta-analysis revealed that few relevant randomized controlled trials measured the clinical effectiveness of surgery on the second eye(10). All the evaluated studies had been conducted over 15 years prior; one then, even before the advent of phacoemulsification(11), and another on a sample comprising only women(6). All the studies were conducted in Europe, none in developing countries such as Brazil.

Visual acuity is used as a parameter for preoperative indications and evaluation of cataract surgery results. Other objective tests, such as visual field measurement, contrast sensitivity tests, and stereopsis, have been adopted to quantify the influence of media opacity on proper vision function. However, such tests do not fully measure the impact of visual dysfunction on individuals' quality of life. Thus, outcome measures focused on symptoms, quality of life, convenience, and treatment costs have been frequently used(12). Therefore, this study used an essential tool, namely, Catquest-9SF, to access the self-reported outcomes of patients undergoing cataract surgery. This tool was recently translated into Brazilian Portuguese and validated(13).

 

METHODS

Study design and participants

This randomized controlled clinical trial with a parallel design was conducted in Conselheiro Lafaiete, Minas Gerais, Brazil. The study was approved by the research ethics committee of Hospital das Clínicas da Universidade Federal de Minas Gerais and was conducted in accordance with the principles of the Declaration of Helsinki.

Between May 2021 and June 2022, 302 patients who were indicated for surgery and on the public health system waiting list were called for evaluation. They provided informed consent after the nature and possible consequences of the study were explained to them. After voluntary acceptance, the patients were included if they met the following criteria: (1) the presence of binocular visual acuity worse or equal to 0.3 logarithm of the minimum angle of resolution (LogMAR) and (2) the need for cataract surgery on both eyes. Patients with cognitive difficulties or unable to understand spoken or written Portuguese, below 18 years old, with ocular comorbidities that may interfere with evaluation or follow-up (amblyopia, prior corneal surgery, clinically significant corneal dystrophies, severe corneal diseases, prior retinal detachment, and neuroophthalmologic disease), and requiring combined surgical procedures on one or both eyes were excluded (Figure 1).

 

 

Sample size calculation

For the sample size calculation, data from similar previous studies that had determined that a 16% difference in vision acuity scores between the Intervention and Control Groups was sufficient and statistically validated was considered(6). The estimated effect size was 0.32, and combined with a test power of 80% and 95% confidence interval, it yielded a sample size of 122 patients per group. An additional 20% was suggested to address probable losses and ensure a sufficient sample size throughout the study, thus indicating a sample size of 146 patients per group.

Randomization and allocation

A simple randomization list based on a random sequence in a 1:1 ratio was computer-generated and preestablished by a statistics professional. After the initial enrollment, the principal investigator provided all the patients with an identification number for convenience, which was allocated sequentially.

The participants were divided into two groups:

a) Intervention Group: patients indicated for surgery on both eyes.

b) Control Group: patients indicated for surgery on only one eye.

If indicated, the patients allocated to the Control Group were invited to undergo surgery on the adelphic eye after the follow-up period.

Monitoring and evaluation procedures

Patients in both groups had a similar follow-up schedule: initial evaluation (day 0) and evaluations on the 1st, 7th, and 30th postoperative days for each operated eye. On average, the total follow-up period was 2 months for the Control Group and 3 months for the Intervention Group. The 1-month difference between the groups generally represented the time between the first and second surgeries in the Intervention Group.

At the initial evaluation, in addition to mandatory ophthalmologic examinations and biometric calculations, all the enrolled patients underwent the following tests: (I) assessment of best-corrected binocular and monocular visual acuity (BCVA) using the Early Treatment of Diabetic Retinopathy Score, with the results converted to LogMAR, (II) cataract classification according to the Lens Opacities Classification System III(14), (III) evaluation of ocular dominance using the hole-in-card test(15), (IV) a stereopsis test using the Stereo Fly Test(16), and (V) an evaluation of self-reported visual function using the translated and validated Brazilian Portuguese version of Catquest-9SF(13)

After the group-specific follow-up period, the participants were again subjected to tests I-V, except II. On average, the final evaluation occurred 1-2 months after the follow-up period. The first surgery was performed on the eye with the worst corrected vision (first option) or on the right eye (by convention) in cases with similar low visual acuity between the eyes.

Self-reported visual function

Catquest-9SF is a tool for the self-assessment of cataract patients' perception of their visual quality of life. This questionnaire, which comprises nine items, measures the visual problems the patient perceives in their daily life. Each item is scored on a scale that contains four numbered options theoretically, patients with high levels of visual impairment should choose the highest-scoring categories (3 or 4, representing greater difficulty/higher dissatisfaction), and those with low levels of impairment should choose the lowest-scoring categories (1 or 2). The questionnaire was translated into Brazilian Portuguese and revalidated in 2022(13).

Surgical procedure

A single experienced surgeon (the primary author) performed all the surgeries. The patients underwent phacoemulsification with foldable intraocular lens implantation. After the administration of mydriatic eye drops and anesthetics, a 2.4-mm corneal tunnel incision and a 1-mm side-port incision were made. Intracameral injection of lidocaine 1% was followed by injection with a viscoelastic substance to perform capsulorhexis and hydrodissection. Then, phacoemulsification was performed using a CataRhex 2 phacoemulsifier(Oertli Hafnerwisenstrasse, Berneck Switzerland) and a 0.9-mm curved tip of the device handpiece. Subsequently, moxifloxacin was injected intracamerally.

Outcomes

The primary outcome of the study was the change in the self-perceived visual quality of life after surgery, as measured by the change in the Catquest-9SF score. The secondary outcomes included changes in binocular visual acuity patterns, stereopsis, and eye dominance patterns after surgery.

Statistical analysis

Qualitative variables were expressed as absolute (n) and relative (%) frequency. The two groups were compared at baseline using a chi-squared test for qualitative variables and the Mann-Whitney U test for quantitative variables.

The results of Catquest-9SF were analyzed using generalized estimating equations, which enable the evaluation of the score variation between groups and in each group separately, considering the times at baseline and the end of follow-up. The same method was employed to assess the following visual functions: binocular visual acuity, stereopsis, and ocular dominance.

All statistical analyses were conducted using SPSS version 25 (IBM-Armonk, New York), with a significance level of 5%.

 

RESULTS

Sample characteristics

This study included 151 patients (77 belonging to the Control Group and 74 to the Intervention Group. The patients' demographic and social characteristics, clinical comorbidities, and specific eye test results are shown in Table 1S, which showed no differences between the Groups.

 

 

Self-reported visual function results

The two groups were compared at baseline, and no difference was observed in the mean Catquest-9SF score (p=0.996), as expected. However, at the end of the study period, it was found that the intervention group had lower scores (lower difficulty/lower dissatisfaction) than the control group (p=0.036). When both groups were compared separately between the preoperative period and the end of the study period, there was a significant reduction in the total score obtained (p=0.0001). Therefore, it can be inferred that cataract surgery on one or both eyes led to a perceived improvement in both groups, although the difference was more significant in the intervention group (Table 1).

 

 

Visual acuity results

Surgery on one or both eyes improved the corrected binocular acuity in both groups. However, the two groups did not significantly differ at the end of the follow-up period (Table 2).

 

 

Stereopsis results

Over the study period, both groups exhibited improved stereopsis results (p=0.000). However, there was a significant reduction in the proportion of individuals with a result worse than 800 arc seconds (ArcSec) after surgery on one or both eyes.

The two groups were compared at the end of the study period, and a significant difference was observed between them (p=0.026). Overall, patients who underwent binocular surgery exhibited better fine depth discrimination than those who underwent monocular surgery (Table 3).

 

 

Ocular dominance results

No significant differences were observed when assessing the percentage of patients who underwent ocular dominance alternation between baseline and the end of the study period considering the same group (p=0.363) (Table 4).

 

 

DISCUSSION

This study evaluated the differences in self-reported visual function, binocular visual acuity, stereopsis, and ocular dominance between patients who underwent monocular surgery and those who underwent binocular surgery. A significant improvement in self-reported visual function, measured using Catquest-9SF, in both groups was improved during the follow-up period. However, at the end of the follow-up period, more significant improvement was noted in those who underwent binocular surgery than in those who underwent monocular surgery. Similar studies have also demonstrated that patients who undergo monocular surgery experience significant improvement in self-reported visual function compared with those who have not yet had surgery on any eye; however, the self-perceived outcomes were significantly better in those who underwent binocular surgery than in those who underwent monocular surgery(17-19).

Arsenault et al. compared the responses to Catquest-9SF among patients who underwent immediate sequential bilateral cataract surgery (surgery on both eyes on the same day), patients who underwent delayed sequential surgery (different days for the two eyes), and patients who underwent monocular surgery. Similar to the findings of this study, those who underwent binocular surgery had significantly lower scores on the questionnaire than those who underwent monocular surgery, indicating that binocular surgery improves self-reported visual function(20).

Furthermore, binocular corrected visual acuity improved in both groups and did not differ between the groups at the end of the study period. As the eye with the poorest vision is the first choice in a surgical sequence, together with the fact that most patients in this study had mild visual impairment(21) (BCVA 0.3-0.5 LogMAR), it can be inferred that cataract surgery, even if monocular, substantially improves binocular visual function.

The improvement in visual acuity in the groups in this study is relevant in that it corroborates the ability of Catquest-9SF to correctly measure self-reported visual function. Previous studies have also demonstrated a direct correlation between responses to Catquest-9SF and improved visual acuity following surgery(13,22,23).

As noted at the end of the study period, the median visual acuity was obtained in the monocular and binocular groups (0.2 and 0.1 LogMAR, respectively). Previous studies have found that modern cataract surgery is successful in most patients with BCVA <0.2 LogMAR(24,25). Despite being performed entirely with public funds in a tertiary hospital not specializing in ophthalmology, the surgeries in this study yielded excellent results, in no way inferior to the results obtained in private environments. Among the factors that contribute to these results are the improved access to basic supplies and equipment at affordable prices over recent decades, innovation of surgical techniques that have increased the degree of surgical reproducibility, experience of surgeons increasingly specializing in this subarea of ophthalmology, and incentives from the public sector in funding actions in this area supporting this surgeries.

As regards stereopsis, a significant improvement was observed in both groups during the segment, that is, although slight, there was also an important improvement in the group undergoing monocular surgery. Depth perception is aided by several "monocular cues" and cannot be explained by binocularity alone or the consequent cortical superposition of fields(26,27). Thus, binocular vision is complex, and the contribution of monocular surgery to stereopsis is conclusive. Nevertheless, patients who underwent binocular surgery were undeniably better able to perceive fine depth than those who underwent monocular surgery, indicating that good binocular vision has advantages in the visual discrimination of space(27).

Over half of the patients evaluated at baseline could not achieve stereoscopic results better than 800 ArcSec. This could be attributed to some specific factors of the sample, such as predominantly elderly individuals with physiological accommodative deficit, low cognitive capacity, and low visual acuity. In addition, several studies have reported that the prevalence of decreased stereopsis in the general population (even in those without known clinical abnormalities) ranges from 3% to over 30%(26).

Finally, at the end of the follow-up period, few individuals achieved more refined stages of depth perception. Stereoacuity is strongly reduced when the visual acuity of one eye differs from that of the other, particularly at higher spatial frequencies. Likewise, when contrast is reduced more in one eye, there is greater impairment of stereoacuity compared to similar contrast reductions in both eyes(26). These observations may be responsible for the low stereoscopic refinement rate.

The ocular dominance did not change in any of the groups. A recent study reported that the ocular dominance changed when the postoperative visual acuity of the nondominant eye improved relative to that of the dominant eye following surgery. However, if surgery on the contralateral eye is performed immediately after surgery on the dominant eye, the dominant eye returns to its initial state(28). Such findings could not be demonstrated in this study. Variability is widely known to exist in the responses to repeated identical dominance tests. Approximately 40% of patients cannot indicate which eye is dominant(29). Furthermore, there is no consensus regarding which of the several tests available is the most accurate(15,30). These facts possibly influenced the findings of this study.

In recent years, substantial technical and technological improvements have been made in cataract surgery, which resulted in a highly reproducible and scalable procedure. However, cataract remains a significant public health concern, particularly in less developed and populous countries. Questions regarding the cost-effectiveness of cataract surgery must be addressed based on local realities. Despite the findings of this study, monocular surgery in situations where resources or opportunities are scarce is an excellent option and provides unquestionable functional gains.

This study has some limitations. First: this is a single-center study with a limited sample size conducted in a city in Minas Gerais. Second: self-reporting questionnaires, such as Catquest-9SF, are subjective as the patient's overall experience can influence the results. Patients dissatisfied with the surgery, the attending physician, or even the lengthy process in the Brazilian public health system may report more vision-related difficulties than those who were satisfied. Third: postoperative residual refraction data, contrast evaluation using specific devices, and more advanced stereopsis tests may facilitate the generation of more relevant data for studies of this complexity.

In conclusion, our results indicate that self-reported visual function and stereopsis are significantly better in patients undergoing binocular surgery than in those undergoing monocular surgery. Binocular visual acuity and ocular dominance did not affect the results of the comparison between the groups. The visual function of both groups underwent positive changes throughout the segment, with no change in ocular dominance.

 

AUTHORS' CONTRIBUTION:

Significant contribution to conception and design: Helmer Magalhães Antunes; Galton Carvalho Vasconcelos; Bruno Lovaglio Cançado Trindade. Data acquisition: Helmer Magalhães Antunes.Data analysis and interpretation: Helmer Magalhães Antunes; Galton Carvalho Vasconcelos; Bruno Lovaglio Cançado Trindade. Manuscript drafting: Helmer Magalhães Antunes. Significant intellectual content of the manuscript: Helmer Magalhães Antunes; Galton Carvalho Vasconcelos; Bruno Lovaglio Cançado Trindade. Final approval of the submitted manuscript: Helmer Magalhães Antunes; Galton Carvalho Vasconcelos; Bruno Lovaglio Cançado Trindade. Statistical analysis: Helmer Magalhães Antunes. Obtaining funding: not applicable. Supervision of administrative, technical, or material support: Helmer Magalhães Antunes. Research group leadership: Galton Carvalho Vasconcelos.

 

REFERENCES

1. Harwood RH, Foss AJ. Second-eye cataract surgery: valuable investment or unaffordable luxury? Age Ageing. 2014;43(3):310-2.

2. Sach TH, Foss AJ, Gregson RM, Zaman A, Osborn F, Masud T, et al. Second-eye cataract surgery in elderly women: a cost-utility analysis conducted alongside a randomized controlled trial. Eye (Lond). 2010;24(2):276-83.

3. Tan AC, Tay WT, Zheng YF, Tan AG, Wang JJ, Mitchell P, et al. The impact of bilateral or unilateral cataract surgery on visual functioning: when does second eye cataract surgery benefit patients? Br J Ophthalmol. 2012;96(6):846-51.

4. Shekhawat NS, Stock MV, Baze EF, Daly MK, Vollman DE, Lawrence MG, et al. Impact of first eye versus second eye cataract surgery on visual function and quality of life. Ophthalmology. 2017; 124(10):1496-503.

5. Meuleners LB, Fraser ML, Ng J, Morlet N. The impact of first- and second-eye cataract surgery on injurious falls that require hospitalisation: a whole-population study. Age Ageing. 2014;43(3):341-6.

6. Foss AJ, Harwood RH, Osborn F, Gregson RM, Zaman A, Masud T. Falls and health status in elderly women following second eye cataract surgery: a randomised controlled trial. Age Ageing. 2006;35(1):66-71.

7. Hayashi K, Hayashi H. Stereopsis in bilaterally pseudophakic patients. J Cataract Refract Surg. 2004;30(7):1466-70.

8. Castells X, Alonso J, Ribó C, Casado A, Buil JA, Badia M, et al. Comparison of the results of first and second cataract eye surgery. Ophthalmology. 1999;106(4):676-82.

9. Castells X, Comas M, Alonso J, Espallargues M, Martínez V, García-Arumí J, et al. In a randomized controlled trial, cataract surgery in both eyes increased benefits compared to surgery in one eye only. J Clin Epidemiol. 2006;59(2):201-7.

10. Frampton G, Harris P, Cooper K, Lotery A, Shepherd J. The clinical effectiveness and cost-effectiveness of second-eye cataract surgery: a systematic review and economic evaluation. Health Technol Assess. 2014;18(68):1-205.

11. Laidlaw DA, Harrad RA, Hopper CD, Whitaker A, Donovan JL, Brookes ST, et al. Randomised trial of effectiveness of second eye cataract surgery. Lancet. 1998;352(9132):925-9.

12. Braithwaite T, Calvert M, Gray A, Pesudovs K, Denniston AK. The use of patient-reported outcome research in modern ophthalmology: impact on clinical trials and routine clinical practice. Patient Relat Outcome Meas. 2019;10:9-24.

13. Antunes HM, Magalhães LC, Vasconcelos GC, Trindade BL, Gonzaga AC, Antunes RP. Catquest-9SF questionnaire: validation of the Portuguese version using the Rasch analysis. Arq Bras Oftalmol. 2022; ;86(2):156-63.

14. Karbassi M, Khu PM, Singer DM, Chylack LT Jr. Evaluation of lens opacities classification system III applied at the slitlamp. Optom Vis Sci. 1993;70(11):923-8.

15. Li J, Lam CS, Yu M, Hess RF, Chan LY, Maehara G, et al. Quantifying sensory eye dominance in the normal visual system: a new technique and insights into variation across traditional tests. Invest Ophthalmol Vis Sci. 2010;51(12):6875-81.

16. Stereo Optical Company Inc. Stereotest-symbols, stereo. Test. 2018.[cited 2023 Mar 3]. Available from: https://www.stereooptical.com/wp-content/uploads/2018/01/LEA-symbols-FLY-2017-User-manual-ONLY-12212017-2.pdf

17. Seth I, Bulloch G, Thornell E, Lundström M, Agarwal S. Catquest-9SF questionnaire shows greater visual functioning in bilateral cataract populations: A prospective study. Indian J Ophthalmol. 2022;70(11):3820-6.

18. Rönbeck M, Lundström M, Kugelberg M. Study of possible predictors associated with self-assessed visual function after cataract surgery. Ophthalmology. 2011;118(9):1732-8.

19. Stolk-Vos AC, Visser MS, Klijn S, Timman R, Lansink P, Nuijts R, et al. Effects of clinical parameters on patient-reported outcome in cataract patients: a multicentre study. Acta Ophthalmol. 2018; 96(6):586-91.

20. Arsenault R, Hébert M, You E, Légaré ME, Mercier M. Perception of visual outcomes in patients after delayed compared with immediately sequential bilateral cataract surgery. J Cataract Refract Surg. 2023;49(2):148-53.

21. Colenbrander A. (2002). Visual Standards aspects and ranges of vision loss with emphasis on population surveys. [cited 2023 Mar 22]. Available from: https://www.researchgate.net/publication/248343777_Visual_Standards_aspects_and_ranges_of
_vision_loss_with_emphasis_on_population_surveys

22. Bando AH, Hamada KU, Nakamura VP, Abe RY, Ferrari PV, Herrerias BT, et al. Long-term visual acuity results from cataract surgery and its association with self-reported visual function: catquest applicability. Arq Bras Oftalmol. 2022;87(3):e2022-0198

23. Adnan TH, Mohamed Apandi M, Kamaruddin H, Salowi MA, Law KB, Haniff J, et al. Catquest-9SF questionnaire: validation of Malay and Chinese-language versions using Rasch analysis. Health Qual Life Outcomes. 2018;16(1):5.

24. Hahn U, Krummenauer F, Kölbl B, Neuhann T, Schayan-Araghi K, Schmickler S, et al. Determination of valid benchmarks for outcome indicators in cataract surgery: a multicenter, prospective cohort trial. Ophthalmology. 2011;118(11):2105-12.

25. Lundström M, Barry P, Henry Y, Rosen P, Stenevi U. Evidence-based guidelines for cataract surgery: guidelines based on data in the European Registry of Quality Outcomes for Cataract and Refractive Surgery database. J Cataract Refract Surg. 2012;38(6):1086-93.

26. Levi DM. Learning to see in depth. Vision Res. 2022;200:108082.

27. Bicas HE. Physiology of binocular vision. Arq Bras Oftalmol. 2004; 67:172-80.

28. Pan S, Tan Q, Song W, Song T, Tao Y. [Law of dominant eye's transformation after cataract phacoemulsification and intraocular lens implantation surgery]. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2018;43(10):1103-11.

29. Kommerell G, Schmitt C, Kromeier M, Bach M. Ocular prevalence versus ocular dominance. Vision Res. 2003;43(12):1397-403.

30. Seijas O, Gómez de Liaño P, Gómez de Liaño R, Roberts CJ, Piedrahita E, Diaz E. Ocular dominance diagnosis and its influence in monovision. Am J Ophthalmol. 2007;144(2):209-16.

Submitted for publication: January 10, 2024.
Accepted for publication: March 22, 2024.

Approved by the following research ethics committee: Hospital das Clínicas da Universidade Federal de Minas Gerais (# 4173014).

Funding: This study received no specific financial support.

Disclosure of potential conflicts of interest: None of the authors have any potential conflicts of interest to disclose.


Dimension

© 2024 - All rights reserved - Conselho Brasileiro de Oftalmologia